#1 Clinical Trials Search in Europe

Morphine Sulfate

Morphine Sulfate, a powerful opioid pain medication, has been the subject of numerous clinical trials to assess its safety, efficacy, and pharmacokinetics in various patient populations. These studies aim to improve our understanding of how Morphine Sulfate works in different formulations, dosages, and patient groups, including those with specific conditions like obstructive sleep apnea, cancer pain, and postoperative pain. The trials also explore the drug’s interactions with food and alcohol, as well as its use in pediatric patients.

Table of Contents

What is Morphine Sulfate?

Morphine Sulfate is a powerful pain-relieving medication that belongs to the opioid class of drugs. It is commonly used to treat moderate to severe pain in various medical situations. Morphine Sulfate is known by several other names, including MS Contin, Roxanol, Kadian, and Avinza[1]. These different names often refer to various formulations or brand names of the same active ingredient.

Uses of Morphine Sulfate

Morphine Sulfate is primarily used for pain management in several conditions:

  • Post-operative pain: It is commonly used to control pain after surgical procedures, especially in cases like laparoscopic sigmoidectomy (a type of colon surgery)[2].
  • Acute pain: It can be used in emergency departments to manage severe acute pain, such as in cases of abdominal pain, flank/lumbar back pain, or pain in the extremities[1].
  • Fracture pain: Morphine can be used to manage pain associated with fractures, particularly proximal femur (hip) fractures[3].
  • Cancer-related pain: While not explicitly mentioned in the provided studies, morphine is widely used in cancer pain management.

How Morphine Sulfate Works

Morphine Sulfate works by binding to specific receptors in the brain and spinal cord called opioid receptors. This binding action changes how the body perceives pain, effectively reducing the sensation of pain. It also can produce feelings of euphoria and relaxation, which is why it’s classified as a controlled substance[1].

Administration Methods

Morphine Sulfate can be administered in several ways:

  • Intravenous (IV): Directly into a vein, often used in hospital settings for quick pain relief[1].
  • Patient-Controlled Analgesia (PCA): A method where the patient can self-administer small doses of morphine through an IV line as needed[2].
  • Oral solution: A liquid form that can be taken by mouth[4].
  • Extended-release tablets: Pills designed to release the medication slowly over time[4].

Effectiveness in Pain Management

Morphine Sulfate is considered highly effective for pain management. Studies have shown its efficacy in various scenarios:

  • In post-operative pain management after procedures like laparoscopic sigmoidectomy, morphine has been compared to other pain management techniques such as epidural anesthesia and nerve blocks[2].
  • For acute pain in emergency settings, morphine has been studied against other pain management options like low-dose ketamine[1].
  • In cases of proximal femur fractures, morphine infusion has been compared to nerve block techniques for pain control[3].

Side Effects and Precautions

While Morphine Sulfate is effective for pain management, it does come with potential side effects and risks:

  • Respiratory depression: Morphine can slow down breathing, which is a particular concern in patients with sleep apnea[5].
  • Nausea and vomiting: These are common side effects, often managed with anti-nausea medications[1].
  • Sedation: Morphine can cause drowsiness and affect alertness[1].
  • Constipation: Opioids like morphine can slow down bowel function.
  • Risk of dependence: Long-term use of morphine can lead to physical dependence and addiction.

Special precautions are needed when using morphine in certain patient groups, such as those with sleep apnea or respiratory conditions[5].

Ongoing Research

Research on Morphine Sulfate is ongoing to better understand its effects and optimize its use:

  • Studies are being conducted to compare morphine with other pain management techniques, such as nerve blocks, for specific types of pain[3].
  • Research is examining the effects of morphine on sleep-disordered breathing in patients with obstructive sleep apnea[5].
  • Investigations are ongoing into different formulations of morphine, such as extended-release tablets, to improve its effectiveness and reduce side effects[4].
Aspect Details
Study Types Bioequivalence, pharmacokinetics, safety, efficacy
Patient Populations Healthy volunteers, cancer patients, postoperative patients, pediatric patients (2-17 years)
Formulations Studied Immediate-release tablets, extended-release tablets, oral solutions, controlled-release capsules
Key Outcomes Measured Pharmacokinetic parameters (Cmax, AUC, Tmax), adverse events, pain control, respiratory function
Special Considerations Food effects, alcohol interactions, use in obstructive sleep apnea patients
Safety Monitoring Adverse events, sedation levels, respiratory depression, vital signs

FAQ

  • What is the purpose of studying Morphine Sulfate in patients with obstructive sleep apnea? The study aims to investigate the effects of morphine on breathing pauses in patients with moderate obstructive sleep apnea (OSA). This is important because morphine can reduce upper airway muscle tone and cause shallow breathing, which may affect breathing function in sleep apnea patients. The results will help doctors make better decisions when prescribing morphine to patients with OSA, especially in urgent situations like after surgery.
  • How is Morphine Sulfate being studied in cancer patients? Clinical trials are comparing different formulations of Morphine Sulfate in cancer patients with pain. For example, one study is assessing the efficacy, patient preference, and side effect profile of a controlled-release morphine formulation taken once daily compared to a twice-daily formulation. The goal is to determine which treatment provides better pain control and potentially improves quality of life for cancer patients.
  • What are researchers trying to learn about Morphine Sulfate's interaction with food? Researchers are conducting bioequivalence studies to understand how food affects the absorption and effectiveness of Morphine Sulfate. These studies compare the drug's behavior in the body when taken with food versus when taken on an empty stomach. This information helps determine if the medication should be taken with or without food and if dosing adjustments are necessary.
  • Why is Morphine Sulfate being studied in pediatric patients? Clinical trials are evaluating the safety and pharmacokinetics of oral Morphine Sulfate in pediatric patients aged 2 to 17 years with postoperative pain. These studies aim to determine appropriate dosing, assess the drug's behavior in children's bodies, and evaluate its safety profile in different age groups. This research is crucial for developing safe and effective pain management strategies for pediatric patients.
  • What are the main safety concerns being monitored in Morphine Sulfate trials? The main safety concerns being monitored include adverse events leading to study discontinuation, serious adverse events, and sedation levels. Researchers are also paying close attention to specific side effects such as respiratory depression, nausea, vomiting, and pruritus (itching). Additionally, vital signs like oxygen saturation levels and respiratory rates are closely monitored to ensure patient safety during the trials.

Ongoing Clinical Trials on Morphine Sulfate

  • Study of Recovery After Surgery for Colorectal Cancer Using Lidocaine and Ropivacaine in Patients Undergoing Laparoscopic Colorectal Cancer Surgery

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of methadone and morphine combination for pain relief in patients with bone metastases from cancer

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Nefopam for Reducing Postoperative Pain in Adults After Total Knee Replacement Surgery

    Recruiting

    3 1 1
    Investigated drugs:
    France

  • Study on the Effects of Morphine Sulfate for Relieving Breathlessness and Cough in Patients with Fibrotic Interstitial Lung Disease

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Pain Relief for Limb Injuries in Children: Comparing Intranasal Fentanyl, Intranasal Ketamine, and Oral Morphine in Patients Aged 2-17 Years

    Recruiting

    4 1 1
    Investigated drugs:
    France

  • Methoxyflurane versus oral oxycodone hydrochloride and morphine sulfate for pain relief in sickle cell disease vaso‑occlusive crises

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of morphine to relieve shortness of breath in patients with amyotrophic lateral sclerosis who have breathing problems

    Not yet recruiting

    3 1 1
    Investigated drugs:
    France

  • Comparing tramadol and morphine for pain relief after laparoscopic abdominal surgery in adults

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    France

Glossary

  • Obstructive Sleep Apnea (OSA): A sleep disorder characterized by repeated pauses in breathing during sleep due to partial or complete blockage of the upper airway.
  • Pharmacokinetics (PK): The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Bioequivalence: The property of two drug products having the same active ingredient, dosage form, strength, and route of administration to be pharmaceutically equivalent and to have similar biological effects when administered.
  • Extended-release (ER): A formulation of a drug designed to release the active ingredient slowly over an extended period, allowing for less frequent dosing.
  • Immediate-release (IR): A formulation of a drug designed to release the active ingredient quickly after administration.
  • Apnea-Hypopnea Index (AHI): A measure used to indicate the severity of sleep apnea, calculated by dividing the number of apneas and hypopneas by the number of hours of sleep.
  • Cmax: The maximum concentration of a drug observed in the blood after administration.
  • Area Under the Curve (AUC): A measure of the total exposure to a drug over time, used in pharmacokinetic studies.
  • Tmax: The time it takes for a drug to reach its maximum concentration in the blood after administration.
  • Naltrexone: An opioid antagonist used to block the effects of opioids and reduce potential side effects during clinical trials.

References

  1. https://clinicaltrials.gov/study/NCT01538745
  2. https://clinicaltrials.gov/study/NCT01825993
  3. https://clinicaltrials.gov/study/NCT05023473
  4. https://clinicaltrials.gov/study/NCT02773316
  5. https://clinicaltrials.gov/study/NCT03127800